DK1689356T3 - Topiske sammensætninger med natriumhyaluronatfragmenter og et retinoid - Google Patents

Topiske sammensætninger med natriumhyaluronatfragmenter og et retinoid

Info

Publication number: DK1689356T3
Authority: DK; Denmark
Prior art keywords: controls; fragments; proliferating cells; retinoid; dermis
Prior art date: 2004-01-29

Application number

DK05717499T

Other languages

English (en)

Inventor

Jean-Hilaire Saurat

Guerkan Kaya

Pascal Bordat

Original Assignee

Fabre Pierre Dermo Cosmetique

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-29

Filing date

2005-01-27

Publication date

2009-03-23

2005-01-27 Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique

2009-03-23 Application granted granted Critical

2009-03-23 Publication of DK1689356T3 publication Critical patent/DK1689356T3/da

Links

239000000203 mixture Substances 0.000 title abstract 2
230000000699 topical effect Effects 0.000 title abstract 2
150000004492 retinoid derivatives Chemical class 0.000 title 1
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical group [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title 1
210000004027 cell Anatomy 0.000 abstract 4
230000002062 proliferating effect Effects 0.000 abstract 3
WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 abstract 2
210000004207 dermis Anatomy 0.000 abstract 2
210000002615 epidermis Anatomy 0.000 abstract 2
208000019028 Epidermal thickening Diseases 0.000 abstract 1
238000011804 SKH1 hairless mouse Methods 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
210000002950 fibroblast Anatomy 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
229940014041 hyaluronate Drugs 0.000 abstract 1
239000003550 marker Substances 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
210000003491 skin Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Birds (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Gerontology & Geriatric Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

DK05717499T 2004-01-29 2005-01-27 Topiske sammensætninger med natriumhyaluronatfragmenter og et retinoid DK1689356T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0400826A FR2865651B1 (fr)	2004-01-29	2004-01-29	Compositions topiques associant des fragments de hyaluronate de sodium et un retinoide utiles en dermatologie cosmetique et medicale
PCT/FR2005/000176 WO2005082327A1 (fr)	2004-01-29	2005-01-27	Compositions topiques associant des fragments de hyaluronate de sodium et un retinoide

Publications (1)

Publication Number	Publication Date
DK1689356T3 true DK1689356T3 (da)	2009-03-23

Family

ID=34746294

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05717499T DK1689356T3 (da)	2004-01-29	2005-01-27	Topiske sammensætninger med natriumhyaluronatfragmenter og et retinoid

Country Status (17)

Country	Link
US (1)	US8968751B2 (da)
EP (2)	EP2208509A3 (da)
JP (2)	JP2007519689A (da)
CN (1)	CN100574742C (da)
AT (1)	ATE418959T1 (da)
AU (1)	AU2005216663B2 (da)
BR (1)	BRPI0507240B8 (da)
CA (1)	CA2553725C (da)
CY (1)	CY1108934T1 (da)
DE (1)	DE602005012049D1 (da)
DK (1)	DK1689356T3 (da)
ES (1)	ES2318469T3 (da)
FR (1)	FR2865651B1 (da)
PL (1)	PL1689356T3 (da)
PT (1)	PT1689356E (da)
SI (1)	SI1689356T1 (da)
WO (1)	WO2005082327A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2037874A1 (en) *	2006-06-28	2009-03-25	Novozymes Biopolymer A/S	Compositions with several hyaluronic acid fractions for cosmetic and medical uses
JP5469455B2 (ja) *	2006-07-03	2014-04-16	ロレアル	少なくとも１種のｃ−グリコシド誘導体及び少なくとも１種のヒアルロン酸を含む組成物及びその化粧料としての使用
WO2008003321A2 (en) *	2006-07-07	2008-01-10	Novozymes Biopolymer A/S	Compositions with several hyaluronic acid fractions for cosmetic use
FR2909560B1 (fr)	2006-12-06	2012-12-28	Fabre Pierre Dermo Cosmetique	Gel d'acide hyaluronique pour injection intradermique
WO2008094910A2 (en) *	2007-01-30	2008-08-07	Cypress Pharmaceutical, Inc.	Hyaluronate compositions
FR2918892B1 (fr) *	2007-07-16	2010-02-12	Fabre Pierre Dermo Cosmetique	Composition dermatologique anti-inflammatoire comprenant des corticoides et des fragments de hyaluronate, et ses utilisations
FR2936708B1 (fr) *	2008-10-03	2012-08-17	Exsymol Sa	Complexe associant un derive organique du silicium avec des fragments calibres d'acide hyaluronique, a action preventive et reparatrice des degradations cutanees.
FR2963240B1 (fr) *	2010-07-28	2013-03-15	Horus Pharma	Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
ES2378028B1 (es)	2012-02-22	2013-02-18	Ignacio Umbert Millet	Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes
EP2854793B1 (fr)	2012-06-01	2021-10-27	Galderma Research & Development	Nanocapsules lipidiques comprenant un rétinoide, nanodispersion et composition les contenant, leur procédé de préparation et leur utilisation en dermatologie
EP2903588B1 (en) *	2012-10-02	2020-02-19	Allergan, Inc.	Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes
CN102961396A (zh) *	2012-12-17	2013-03-13	程玉李	透明质酸金属盐在制备治疗皮肤病药物中的应用、其药物组合物及其制备方法
FR3020570B1 (fr) *	2014-04-30	2017-07-21	Pierre Fabre Dermo Cosmetique	Association d'un acide hyaluronique et d'un polysaccharide sulfate
WO2018122344A1 (en) *	2016-12-29	2018-07-05	Nestlé Skin Health Sa	Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis
EP3562469A1 (en)	2016-12-29	2019-11-06	Nestlé Skin Health SA	Micro- or nanoparticular vesicles comprising crosslinked hyaluronic acid, compositions comprising the same and method for their use in skin care
JP7475018B2 (ja) *	2017-07-25	2024-04-26	ピアス株式会社	皮膚外用組成物
WO2019022250A1 (ja) *	2017-07-28	2019-01-31	国立大学法人九州大学	水溶性有効成分の放出が制御された経皮吸収組成物
WO2019068288A1 (de)	2017-10-04	2019-04-11	Berlimed International Research Gmbh	Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung
CN111253504A (zh) *	2020-03-19	2020-06-09	上海缓释新材料科技有限公司	一种无毒副作用的维生素a衍生物及其制备方法
EP4176867A1 (fr)	2021-11-03	2023-05-10	Term Helvet SA	Extrait de plante et son utilisation dans des compositions à usage topique
FR3130156B1 (fr) *	2021-12-10	2025-08-01	Lvmh Rech	Association d’un acide hyaluronique réticulé, de haut poids moléculaire et d’un acide hyaluronique non réticulé, de bas poids moléculaire.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4303676A (en) *	1980-03-21	1981-12-01	Balazs Endre A	Hyaluronate based compositions and cosmetic formulations containing same
IT1212892B (it) *	1983-10-11	1989-11-30	Della Valle Francesco	Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
IT1229075B (it) *	1985-04-05	1991-07-17	Fidia Farmaceutici	Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
NO169637C (no) *	1983-10-11	1992-07-22	Fidia Spa	Fremgangsmaate for fremstilling av terapeutisk aktive hyaluronsyre-fraksjoner
US4826828A (en) *	1985-04-22	1989-05-02	Avon Products, Inc.	Composition and method for reducing wrinkles
WO1986006275A1 (en)	1985-04-22	1986-11-06	Avon Products, Inc.	Composition and method for reducing wrinkles
JP2532495B2 (ja)	1987-08-06	1996-09-11	ポーラ化成工業株式会社	皮膚化粧料
GB2228736A (en) *	1989-02-10	1990-09-05	Sterivet Lab Ltd	Cosmetic formulation
ES2070335T3 (es) *	1989-09-12	1995-06-01	Shiseido Co Ltd	Procedimiento para la produccion de acido hialuronico de bajo peso molecular.
JPH04505774A (ja) *	1989-09-12	1992-10-08	株式会社資生堂	低分子量ヒアルロン酸の製造方法
CA2061703C (en) *	1992-02-20	2002-07-02	Rudolf E. Falk	Formulations containing hyaluronic acid
US5977088A (en) *	1991-07-03	1999-11-02	Hyal Pharmaceutical Corporation	Formulations containing hyaluronic acid
JP2720256B2 (ja) *	1992-07-13	1998-03-04	株式会社資生堂	皮膚外用剤
ES2191664T5 (es)	1992-07-13	2008-02-16	Shiseido Company, Ltd.	Composicion para preparacion dermatologica.
AR006049A1 (es) *	1996-03-01	1999-07-21	Johnson & Johnson Consumer	Una emulsion de aceite en agua
JPH11279042A (ja)	1998-03-30	1999-10-12	Shiseido Co Ltd	皮膚外用剤
DE59906391D1 (de) *	1998-12-23	2003-08-28	Esparma Gmbh	Mittel zum schutz der haut enthaltend hydrolysierte hyaluronsäure
JP3230579B2 (ja)	1999-06-01	2001-11-19	株式会社ファンケル	化粧料
KR100332031B1 (ko) *	1999-06-03	2002-04-10	서경배	피부 주름의 개선 및 생성 억제 효과를 갖는 외용제 조성물
DE19932197A1 (de)	1999-07-09	2001-01-18	Neudecker Birgit	Topisch anzuwendendes Mittel mit schützender und regenerativer Wirkung
US6426081B1 (en) *	1999-11-30	2002-07-30	Myong Hun Chong	Cosmetic firming formulation
JP2002284662A (ja)	2001-03-27	2002-10-03	Kanebo Ltd	皮膚外用剤組成物
ITMI20032019A1 (it)	2003-10-17	2005-04-18	Fidia Farmaceutici	Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono

2004
- 2004-01-29 FR FR0400826A patent/FR2865651B1/fr not_active Expired - Lifetime
2005
- 2005-01-27 ES ES05717499T patent/ES2318469T3/es not_active Expired - Lifetime
- 2005-01-27 US US10/587,652 patent/US8968751B2/en active Active
- 2005-01-27 CN CN200580003661A patent/CN100574742C/zh not_active Expired - Fee Related
- 2005-01-27 JP JP2006550245A patent/JP2007519689A/ja active Pending
- 2005-01-27 WO PCT/FR2005/000176 patent/WO2005082327A1/fr not_active Ceased
- 2005-01-27 SI SI200530554T patent/SI1689356T1/sl unknown
- 2005-01-27 BR BRPI0507240A patent/BRPI0507240B8/pt not_active IP Right Cessation
- 2005-01-27 EP EP08167769.2A patent/EP2208509A3/fr not_active Withdrawn
- 2005-01-27 DK DK05717499T patent/DK1689356T3/da active
- 2005-01-27 PL PL05717499T patent/PL1689356T3/pl unknown
- 2005-01-27 AU AU2005216663A patent/AU2005216663B2/en not_active Ceased
- 2005-01-27 PT PT05717499T patent/PT1689356E/pt unknown
- 2005-01-27 EP EP05717499A patent/EP1689356B1/fr not_active Expired - Lifetime
- 2005-01-27 DE DE602005012049T patent/DE602005012049D1/de not_active Expired - Lifetime
- 2005-01-27 CA CA2553725A patent/CA2553725C/fr not_active Expired - Lifetime
- 2005-01-27 AT AT05717499T patent/ATE418959T1/de active
2009
- 2009-03-23 CY CY20091100327T patent/CY1108934T1/el unknown
2012
- 2012-08-01 JP JP2012170756A patent/JP2012255001A/ja active Pending

Also Published As

Publication number	Publication date
EP2208509A2 (fr)	2010-07-21
AU2005216663A1 (en)	2005-09-09
BRPI0507240B1 (pt)	2017-12-12
PT1689356E (pt)	2009-02-25
AU2005216663B2 (en)	2010-09-30
ES2318469T3 (es)	2009-05-01
CA2553725C (fr)	2013-10-01
BRPI0507240B8 (pt)	2021-05-25
US20070172442A1 (en)	2007-07-26
DE602005012049D1 (de)	2009-02-12
CN1913868A (zh)	2007-02-14
CY1108934T1 (el)	2014-07-02
EP1689356A1 (fr)	2006-08-16
HK1094941A1 (zh)	2007-04-20
FR2865651B1 (fr)	2007-09-28
ATE418959T1 (de)	2009-01-15
JP2012255001A (ja)	2012-12-27
CN100574742C (zh)	2009-12-30
BRPI0507240A (pt)	2007-06-26
US8968751B2 (en)	2015-03-03
SI1689356T1 (sl)	2009-04-30
PL1689356T3 (pl)	2009-06-30
CA2553725A1 (fr)	2005-09-09
EP2208509A3 (fr)	2015-08-05
EP1689356B1 (fr)	2008-12-31
JP2007519689A (ja)	2007-07-19
WO2005082327A1 (fr)	2005-09-09
FR2865651A1 (fr)	2005-08-05

Publication	Publication Date	Title
CY1108934T1 (el)	2014-07-02	Τοπικες συνθεσεις οι οποιες συνδυαζουν κλασματα υαλουρονικου νατριου και ενα ρετινοειδες
JP6412881B2 (ja)	2018-10-24	サリチル酸をベースとしたスージング化粧用組成物
US20200009123A1 (en)	2020-01-09	Method of treating a skin condition
US20110236325A1 (en)	2011-09-29	Methods to treat or prevent a skin condition using a nell1 peptide
ATE533795T1 (de)	2011-12-15	Neutralisiertes kationisches polymer, zusammensetzung mit dem besagten polymer und kosmetisches behandlungsverfahren
PT1294353E (pt)	2006-07-31	Utilizacao do enantiomero (r) do acido lipoico em composicoes cosmeticas e dermatologicas
CN101926741A (zh)	2010-12-29	一种活肤菁华及含有该活肤菁华的护肤品
WO2008145692A3 (en)	2009-04-09	Cosmetic composition comprising an active agent capable of stimulating tensin 1 expression
ATE383893T1 (de)	2008-02-15	Verwendung von oligosacchariden zur stimulierung der produktion von beta-endorphin
JP2017511346A (ja)	2017-04-20	皮膚を水和させるための美容組成物
KR20200031665A (ko)	2020-03-24	외용 조성물
WO2000057836A3 (fr)	2001-05-17	Compositions cosmetiques ou dermatologiques contenant au moins une substance destinee a augmenter la fonctionnalite et/ou l'expression des recepteurs membranaires cd44 des cellules de la peau
FR2883470B1 (fr)	2011-03-25	Kit de maquillage et/ou de soin susceptible de procurer un effet volumateur
DK1635776T5 (da)	2009-04-27	Lipidoverf ringsproteinsystemer samt deres kosmetiske dermatologiske anvendelse
MXPA04012527A (es)	2005-06-08	Tratamientos para el cabello y las unas usando alcanolaminas.
CN104740677B (zh)	2017-06-06	一种皮肤医用修复敷料及其制备方法
US20100098732A1 (en)	2010-04-22	Methods, processes and compositions comprising the protein calmodulin (cam) for treatment of damaged or aging skin, and/or hair loss
RU2004119850A (ru)	2005-03-20	Композиция на основе сложного диосгенина для топического нанесения
CA2448596C (en)	2010-02-23	Topical treatments using alkanolamines
ATE483465T1 (de)	2010-10-15	Verwendung eines gleditsia-extrakts für kosmetik und dermatologie
DE502005001398D1 (de)	2007-10-18	Hautpflegeprodukt enthaltend Ursolsäure und Ginkgo-Extrakt
WO2016102969A1 (en)	2016-06-30	Inhibition of hair growth
Łubkowska et al.	2010	The use of synthetic polypeptides in cosmetics
GB2626818A (en)	2024-08-07	Method of improving the appearance of the skin
CN105434202A (zh)	2016-03-30	一种功能型高吸收性面膜